New study reveals promising drug target for treating osteoporosis
Drug Discovery World
JUNE 25, 2024
Researchers have identified a novel target downstream of parathyroid hormone (PTH) signalling that suppresses bone formation in osteoporosis. Induction of parathyroid hormone (PTH) signalling using the PTH-derived peptide – teriparatide, has demonstrated strong bone-promoting effects in patients with osteoporosis.
Let's personalize your content